ðŸð± ç¬ç«ãã¥ãŒã¹ â 2026.04.21
ç¬8 ïŒ ç«5 ïŒ èš13ä»¶
ðŸ ç¬ãã¥ãŒã¹ â 2026.04.21
æ¬æ¥ 8ä»¶
1. â ïž ãªã³ãŒã«ã»å®å šæ å ±
ãã¥ãŒã¯ãŒã«ãã»ã¹ã¯ãªã¥ãŒã»ã¯ãŒã ïŒNWSïŒããããµã¹åœå¢90ãã€ã«ãžè¿è¿«ââç¬ã®ææäŸç¢ºèªãFDAã4æ17æ¥ä»ã§4è¬å€ã远å ç·æ¥æ¿èª
ð 2026.04.13
ç±³åœèŸ²åçïŒUSDAïŒãšç±³åœç£å»åž«äŒïŒAVMAïŒã¯4æäžæ¬ããã¥ãŒã¯ãŒã«ãã»ã¹ã¯ãªã¥ãŒã»ã¯ãŒã ïŒNWSãCochliomyia hominivoraxïŒã®çºçãã¡ãã·ã³ã»ããšãã¬ãªã³å·ã¢ã³ãã¬ãŒã§ç¢ºèªããããšçºè¡šãããåå°ã¯ãããµã¹åœå¢ãŸã§çŽ90ãã€ã«ïŒçŽ145kmïŒã2024幎11æä»¥æ¥ãã¡ãã·ã³å šåã§ç¬ãžã®ææäŸã3,000件以äžã«éããŠããããããµã¹å·ã¯éåžžäºæ 宣èšãçºä»€æžã¿ã ãNWSã¯åç©ã®å·å£ã«åµãç£ã¿ä»ããåµåãã幌è«ãççµç¹ãé£ãèããå¯çè«ã§ãé©åãªæ²»çãªãã§ã¯é節ãªçµç¹å£æ»ãæ»äº¡ã«ã€ãªããã
ç¬ã»ç«ã»éЬã»å®¶çãåããææãªã¹ã¯ããããFDAã¯4æ17æ¥ä»ã®é£éŠå®å ±ïŒFederal RegisterïŒã§æ°ãã«4çš®ã®åç©è¬ã®ç·æ¥äœ¿çšæ¿èªïŒEUAïŒãä»äžãããããŸã§ã®æ¿èªæžã¿æ²»çè¬ïŒCredelio Quattro-CA1ã»NexGardïŒãšåãããŠéžæè¢ãæ¡å ããããåœå¢å°åž¯ãŸãã¯æè¿ã¡ãã·ã³ã蚪ããç¬ã®é£Œãäž»ã¯ãå·ãç®èç°åžžãèŠã€ããéã«çŽã¡ã«ç£å»åž«ãžçžè«ããããšãç±³åœæ¬åã§ã®çºçã¯çŸæç¹ã§ç¢ºèªãããŠããªãããAVMAã¯å šç£å»åž«ã«æ©æçºèŠã»è¿ éå ±åã®åŸ¹åºãåŒã³ãããŠããã
ð https://www.avma.org/news/us-response-ramps-new-world-screwworm-nears-texas-border
ð·ïž ãªã³ãŒã«ã»å®å šæ å ±
2. 𧬠ç ç©¶ã»ç§åŠ
ç¬ç±æ¥ã³ãããŠã€ã«ã¹ãCCoV-HuPn-2018ããããã«æææ¡å€§ââCDCããã³ãããã¯æœåšãªã¹ã¯ãåããŠè©³çްè©äŸ¡ïŒEmerging Infectious Diseases, January 2026ïŒ
ð 2026.01.01
ç±³CDCãçºè¡ããç§åŠèªãEmerging Infectious Diseasesã2026幎1æå·ã«æ²èŒãããã¬ãã¥ãŒè«æã§ãç¬ã³ãããŠã€ã«ã¹ã®äžå€ç°æ ªãCCoV-HuPn-2018ããããã®åŒåžåšçŸæ£ãåŒãèµ·ãããŠããå¯èœæ§ãåããŠè©³çްã«è©äŸ¡ããããåãŠã€ã«ã¹ã¯2018幎ã«ãã¬ãŒã·ã¢ã§èºçãçºçããå°å ããåããŠåé¢ããããã®åŸã¿ã€ã»ãããã ã»ç±³åœã¢ãŒã«ã³ãœãŒå·ã§ãåŒåžåšæ£è ããæ€åºããããªã©ããã§ã«è€æ°å€§éžã§åŸªç°ããŠããããšãæããã«ãªã£ããç¹ã«åé¡ãªã®ã¯ãçŸåšã®æšæºçãªåŒåžåšææçããã«æ€æ»ã§ã¯ãã®ãŠã€ã«ã¹ãæ€åºã§ããªãç¹ã§ããåå äžæã®èºçããšããŠèŠéãããŠããææäŸãå€ããšèè ãã¯èŠåããŠããã
çŸæç¹ã§ã¯é »åºŠã®é«ãé節ãªçŸæ£ãåŒãèµ·ãããšã¯èšŒæãããŠããªããããããžã®é©å¿ãé²ãã§ããå¯èœæ§ã瀺åããæèŠãå ±åãããŠãããç£èŠäœå¶ã®åŒ·åãšè¿ éãªèšºæããŒã«éçºãæ¥åãšãããŠãããç¬ã¯ãã®ãŠã€ã«ã¹ã®èªç¶å®¿äž»ã§ããããææããç¬ãç¡çç¶ã§ã人ãžã®æææºã«ãªãåŸããã¯æªè§£æã飌ãäž»ãžã®å ·äœçãªè¡åæéã¯ãŸã ãªãããå ç«äœäžè ã乳幌å ãããå®¶åºã§ã¯ç¹ã«è¡ç管çã®åŸ¹åºãæãŸããã
ð https://wwwnc.cdc.gov/eid/article/32/1/25-1764_article
ð·ïž ç ç©¶ã»ç§åŠ
3. 𥩠æ é€ã»é£äºã»ãµããª
è»é¡ïŒã·ãŸãããªãŠã ïŒç±æ¥ãªã¡ã¬3ãµããªãéæ²¹ã®æç¶å¯èœãªä»£æ¿åãšããŠç¢ºèªââDHAäžæã»è¢«æ¯æ¹åã»ã³ã¬ã¹ãããŒã«äœäžãããŒã°ã«ã§å®èšŒ
ð 2025.12.01
Animal Feed Science and Technologyèªã«æ²èŒãããç ç©¶ã§ã忥µç£åŸ®çްè»é¡ã·ãŸãããªãŠã å±ïŒSchizochytrium sp.ïŒããåŸãããè»é¡ç²æ«ããã³è»é¡ãªã€ã«ããéæ²¹ã«å¹æµããæå¹æ§ãšå®å šæ§ãç¬ã§ç€ºãããšã確èªãããã24é ã®ããŒã°ã«ã«è»é¡ç²æ«ã»è»é¡ãªã€ã«ã»éæ²¹ã®3çš®ã28æ¥é絊äžããçµæãè»é¡ç±æ¥ãµããªã¯ããããè¡æž DHAæ¿åºŠãææã«äžæããïŒæå€§0.265±0.05 g/LïŒã被æ¯ã®è¶ã質æãæ¹åããæé žåèœã®åäžã確èªããããããã«è»é¡ç²æ«ã¯ç·ã³ã¬ã¹ãããŒã«ãã³ã³ãããŒã«çŸ€ã®69.4%ã«äœäžãããè質æ¹å广ãèŠãããã
å®å šæ§ææšïŒALTã»ALPã»ACPïŒã¯å šã°ã«ãŒãã§å€åãããå¯äœçšãèªããããªãã£ããéã«å¯Ÿããã¢ã¬ã«ã®ãŒãæã€ç¬ããåç©æ§åæãé¿ããã飌ãäž»ã«ãšã£ãŠç¹ã«æ³šç®ãããçµæã ãä¹±ç²ãæµ·æ°Žæž©äžæã§äŸçµŠãäžå®å®ã«ãªãã€ã€ããéæ²¹ã®ä»£æ¿ãšããŠãè»é¡ç±æ¥ãªã¡ã¬3ã¯ä»åŸã®ãµããªã¡ã³ãåžå Žãå€ããå¯èœæ§ããããç£å»åž«ãšã®çžè«ã®ãããèªåã®ç¬ã®ç¶æ ã«åã£ã補åãéžã¶ããšãæšå¥šãããã
ð https://www.sciencedirect.com/science/article/abs/pii/S221192642500181X
ð·ïž æ é€ã»é£äºã»ãµããª
4. 𥩠æ é€ã»é£äºã»ãµããª
åžè²©ã®ç¬ç«ãµããª70補åã培åºåæââééå±ã»å¿ é ããã©ã«ã®å®æ ãã»ã¬ã³æªç³åã倿°å€æïŒJournal of Animal Physiology and Animal Nutrition, 2026ïŒ
ð 2026.03.01
Journal of Animal Physiology and Animal Nutritionã«æ²èŒãããç ç©¶ïŒPestalozziãïŒã§ã¯ãç±³åœã§åžè²©ãããŠããç¬ç«åããµããªã¡ã³ã70補åã«ã€ããŠã5çš®ã®å¿ é ããã©ã«ãš12çš®ã®ééå±ã®å®éã®å«æéãåæãããæã泚ç®ãã¹ãç¹ã¯ãäºéïŒ68補åã«å«æïŒã®æ¬¡ã«å€ãã£ãã®ãããã±ã«ïŒ66補åïŒã§ãããå¿ é æ é€çŽ ã§ããã»ã¬ã³ã52補åããæ€åºãããã«ãããããããæåãšããŠç³åãããŠããã®ã¯ããã10補åã«éããªãã£ãããšã ããŸããéã¯16補åïŒäžå€®å€0.145mg/kgïŒãã«ãããŠã ã¯10補åïŒäžå€®å€0.115mg/kgïŒããæ€åºããããããªãªãŠã ã»æ°Žéã»ã¿ãªãŠã ã¯å šè£œåã§äžæ€åºã ã£ãã
æããªã®ã¯ãæå€§è容éïŒMTLïŒãè¶ ãã補åã¯1ä»¶ããªããã©ãã«æç€ºéãã«äœ¿çšããéãæ¥æ§æ¯æ§ãªã¹ã¯ã¯äœããšã®è©äŸ¡ã ããã ããç¬ç«ã«åºæã®MTLããŒã¿ãäžè¶³ããŠãããããããåºæºã®å€æ¿ã§è©äŸ¡ãããŠãããç ç©¶è ã¯æ ¢æ§çãªé«æåãªã¹ã¯ã®è§£æã«åãã远å ç ç©¶ãåŒ·ãæ±ããŠãããè€æ°çš®ã®ãµããªãçµã¿åãããŠçµŠäžããŠããå Žåããé·æäœ¿çšã®å Žåã¯ç¹ã«æ³šæãå¿ èŠã ãè³Œå ¥åã«æå衚瀺ãå¿ ã確èªããäžæãªç¹ã¯ç£å»åž«ã«çžè«ããããæšå¥šãããã
ð https://pubmed.ncbi.nlm.nih.gov/41764772/
ð·ïž æ é€ã»é£äºã»ãµããª
5. 𧬠ç ç©¶ã»ç§åŠ
ç¬ã¯ããã®å åæ³æ¹ä¹±ç©è³ªïŒEDCïŒæé²ãå è¡æ€åºãããã»ã³ããã«åç©ãââãããããŒãäžBPAã»PBDEãå¥åº·ã«äžãããªã¹ã¯ïŒFrontiers in Endocrinology, 2026ïŒ
ð 2026.04.01
Frontiers in Endocrinologyèªã«æ²èŒããã2026幎ã®ç ç©¶æŠèª¬ïŒEditorialã·ãªãŒãºç¬¬2å·»ïŒããç¬ãããã®å åæ³æ¹ä¹±ååŠç©è³ªïŒEDCïŒæé²ãå è¡ããŠèŠåãããã»ã³ããã«åç©ããšããŠæ©èœãããšããæ°ããªèŠç¹ãæç€ºãããç¬ã¯ãããšåã宀å 空éã«æ®ãããåæ§ã®å å·¥é£åã»é²çåŠçãããå®¶å ·ã»èŸ²è¬åŠçãããèçã«ãããããªãããããçã寿åœã§å¥åº·åœ±é¿ãçŸãããç ç©¶ã§ã¯ç¬ã®ç²Ÿæ¶²å質äœäžãç²ç¶è ºé害ãç³å°¿ç ããããè çŸæ£ããããããããªèåãžãã§ãã«ãšãŒãã«ïŒPBDEïŒã»BPAã»ãã€ã³ããã·ã³ã»æ€ç©æ§ãšã¹ããã²ã³ãªã©åçš®EDCãšã®é¢é£ã§å ±åãããŠãããããã®ç«åŠç ç©¶ãšäžŠè¡ããååã確èªãããŠãããããã«ãç¬ã®åŸæ¶²ãEDCæé²ã¢ãã¿ãªã³ã°ã®é䟵襲çãã€ãªããŒã«ãŒãšããŠæŽ»çšããç ç©¶ãé²è¡äžã ã
ãã®ç ç©¶ã飌ãäž»ã«äŒããã¡ãã»ãŒãžã¯æç¢ºã ââãããããŒãã®åè³ªéžæãå®¶åºå ã®ååŠç©è³ªæŽé²ãæžããããšããç¬ã®é·æçãªå¥åº·ãå®ãã ãã§ãªããããå®¶æã®å¥åº·ãªã¹ã¯ã®ææšã«ããªãåŸããšããç¹ã ãç¹ã«é£çæã䜿ããããœãã¡ããæ®ºè«å€æ£åžåŸã®èã§ã®ãããæ»åšã«ã¯çæãå¿ èŠãšãããã
ð https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1837257/full
ð·ïž ç ç©¶ã»ç§åŠ
6. ð¥ å»çã»çŸç ã»äºé²
å€åœ¢æ§é¢ç¯çãæ±ããç¬ã®ãæ ¢æ§çŒçèªèã¹ã±ãŒã«ïŒCPPSïŒããéçºã»åŠ¥åœæ§æ€èšŒââVeterinary Record 2026ã飌ãäž»ãçŒçãæ©æã«çºèŠãç£å»åž«ãšé£æºã§ããããŒã«
ð 2026.03.15
Veterinary RecordïŒè±åœç£å»åž«äŒèªïŒ2026幎æ²èŒã®è«æïŒBatistaãïŒã§ãç¬ã®å€åœ¢æ§é¢ç¯çïŒOAïŒã«äŒŽãæ ¢æ§çŒçã飌ãäž»ãèªèã»è©äŸ¡ããããã®ãæ ¢æ§çŒçèªèã¹ã±ãŒã«ïŒCPPSïŒããéçºã»åŠ¥åœæ§æ€èšŒããããå€åœ¢æ§é¢ç¯çã¯æç¬ã®20ã37%ã«èªããããæãäžè¬çãªçŒççŸæ£ã ããç¬ã¯çã¿ãé ãåŸåããããã飿¬²ã¯ããããå¯ãŠã°ãããçšåºŠã®å€åãèŠèœãšããããããæ¬ã¹ã±ãŒã«ã§ã¯ã以åãšæ¯ã¹ãè¡åå€åïŒéã³ãžã®ç©æ¥µæ§ã»èµ·åºæã®ããã°ãã»æ®µå·®ãžã®æåŠæãªã©ïŒã飌ãäž»ç®ç·ã§è©äŸ¡ããOAã®çŒçéçåºŠãšææãªçžé¢ã確èªãããã
èšåºçæçŸ©ã¯å€§ãããæ¬ããŒã«ã¯èšºå¯æã«é£Œãäž»ãã詳ããæ å ±ãåŒãåºããç£å»åž«ãšã®ã³ãã¥ãã±ãŒã·ã§ã³ãæ¹åãããšãšãã«ãåšå® ã§ã®ã¢ãã¿ãªã³ã°ãéããæ©æä»å ¥ãå¯èœã«ãããOAã¯é©åã«ç®¡çããã°ç¬ã®ç掻ã®è³ªïŒQoLïŒãå€§å¹ ã«æ¹åã§ããçŸæ£ã§ããã飌ãäž»ããããã¯ãã ã®èåã§ã¯ãªãçã¿ãããããªãããšæ°ã¥ãããã®å®è·µçããŒã«ãšããŠæ³šç®ããããæ©ãæ¹ã®ããã¡ãªããæ®µå·®ãå«ãããæ«ã§ãããããšãå«ããå Žåã¯ç£å»åž«ã«çžè«ãã
ð https://bvajournals.onlinelibrary.wiley.com/doi/10.1002/vetr.5664
ð·ïž å»çã»çŸç ã»äºé²
7. ðïž ãã¬ãŒãã³ã°ã»è¡åç§åŠ
ä»å©ç¬ãšäººã®ãéèšèªã±ã¢ãã³ãããè§£æââèšèã«é Œããªãçžäºä¿¡é Œãšèªã¿åãã§æãç«ã€åæ¹åã®ã±ã¢é¢ä¿ïŒApril 2026ïŒ
ð 2026.04.10
medicalxpress.comãå ±ãã2026幎4æã®ç ç©¶ã«ãããšãä»å©ç¬ãšäººã®éã«åœ¢æãããã±ã¢é¢ä¿ã¯ãèšèªã«äŸåãããéèšèªçãªä¿¡é Œãšçžäºã®ãèªã¿åããã«ãã£ãŠæãç«ã€ããšãæããã«ãªã£ããç ç©¶ã§ã¯13çµã®ä»å©ç¬ãšäœ¿çšè ã®ãã¢ã察象ã«ãã€ã³ã¿ãã¥ãŒã»æ°æèªç芳å¯ã»åçèšé²ãçµã¿åããã質çç ç©¶ã宿œãç¬ã¯äœ¿çšè ã®å¥åº·ç¶æ ã»æ°åã»å§¿å¢ã»è¡åãã¿ãŒã³ãåžžã«èгå¯ããææ çãµããŒãã»ç§»åè£å©ã»å¥åº·ã¢ãã¿ãªã³ã°ãç©æ¥µçã«æäŸããŠãããäžæ¹ã®äœ¿çšè ããç¬ã®çŽ°åŸ®ãªãµã€ã³ãèªã¿åãããšã§ç¬ã®ç²åŽãäžå¿«æã«æ°ã¥ããçžäºã«ã±ã¢ãåãé¢ä¿ã圢æãããŠããã
ãç¬ã人ã®ããã«åãããšããäžæ¹çãªèŠæ¹ãèŠããã人ãšç¬ãäºãã«ã±ã¢ãåãå ±äŸåçãªããŒãããŒã·ããããšããŠä»å©ç¬é¢ä¿ãæãçŽãããšã§ãèšç·Žã»çŠç¥ç®¡çã»åŒéåŸã®ã±ã¢ã«æ°ããªèŠç¹ãããããå¯èœæ§ããããäžè¬ã®ãããç¬ãšã®ç掻ã«ãããŠãããç¬ã¯äœã蚎ããŠãããããéãã«èгå¯ããããšããæ·±ãçµåœ¢æã𿩿å¥åº·ç°åžžæ€ç¥ã«åœ¹ç«ã€ããšãæ¹ããŠç€ºããŠããã
ð https://medicalxpress.com/news/2026-04-dogs-reveal-bond-built-nonverbal.html
ð·ïž ãã¬ãŒãã³ã°ã»è¡åç§åŠ
8. ð¥ å»çã»çŸç ã»äºé²
2026幎AAHAè «çã¬ã€ãã©ã€ã³å ¬éââãããã€ãç£å»åž«ã䜿ããç¬ç«ãã蚺çã®æ°æéãgilvetmabçã®å ç«çæ³ãå æ¬ïŒAAHA, January 2026ïŒ
ð 2026.01.20
ç±³åœåç©ç é¢åäŒïŒAAHAïŒã¯2026幎1æãå°éè «çç§ã ãã§ãªã**äžè¬ã®ãããã€ãç£å»åž«**ãæŽ»çšã§ããå æ¬çãªè «ç蚺çã¬ã€ãã©ã€ã³ãå ¬éããããããŸã§è «çç§å°éå»åãã®æ å ±ãå€ãã£ãäžãä»åã®ã¬ã€ãã©ã€ã³ã¯ããã©ã€ããªã±ã¢ã¯ãªããã¯ã§ã®ããæ€åºã»ç æåé¡ã»ç®¡çã»ããŒã ã¯ãŒã¯ãããŒããéç¹ã«èšèšãããæ¥åžžèšºçãžã®ãã察å¿ã®çµã¿èŸŒã¿ãä¿é²ããçãããããç¹ã«æ³šç®ãããã®ã¯å ç«çæ³ã»ã¯ã·ã§ã³ã§ãåã®æ¡ä»¶ä»ãã©ã€ã»ã³ã¹ãåããç¬ã®æPD-1ã¢ãã¯ããŒãã«æäœãgilvetmabïŒMerckïŒãïŒè¥æºçްèè «ã»é»è²è «å¯Ÿè±¡ïŒããELIAS Cancer ImmunotherapyïŒç¬ã®éªšèè «ïŒãªã©ãæç¢ºã«äœçœ®ã¥ããããã
ã¬ã€ãã©ã€ã³ã¯ãŸããååŠçæ³å®å šç®¡çã»çŒçè©äŸ¡ã»QoLè©äŸ¡ã»èšåºè©Šéšãžã®ç޹ä»ãããŒãå«ã¿ã飌ãäž»ãšã®ã³ãã¥ãã±ãŒã·ã§ã³æ¯æŽããŒã«ãæäŸãããç¬ã®ããçºççã¯å¹Žã å¢å ããŠããïŒæ»å ã®æå€§50%ãšãããããïŒãå°éç é¢ãžã®ç޹ä»åã«äžè¬ã¯ãªããã¯ãé©åãªåæå¯Ÿå¿ãè¡ããäœå¶æŽåã¯é£Œãäž»ã«ãšã£ãŠãæå ±ã ãæç¬ã«äœè¡šã®ãããã»æ¥æ¿ãªäœéæžå°ã»åå äžæã®è·è¡ãªã©ã®ç°å€ãæãããããããã€ãå»ãžã®æ©ãã®çžè«ãã
ð https://www.aaha.org/resources/2026-aaha-oncology-guidelines-for-dogs-and-cats/
ð·ïž å»çã»çŸç ã»äºé²
ð¡ 仿¥ã®ã¯ã³ãã€ã³ã
ãã¥ãŒã¯ãŒã«ãã»ã¹ã¯ãªã¥ãŒã»ã¯ãŒã ã®è åšãåœå¢ã«è¿«ããªããç¬ã®ç®èãå·å£ãžã®æ³šæãæ¹ããŠéèŠã«ãªã£ãŠããŸããå·ãæ²»ããªããè ¢ããã®ãèŠãããç°åžžãªã«ããããããªã©ã®çç¶ãçºèŠããããããã«ç£å»åž«ãžããŸããæ®æ®µãã䜿ã£ãŠãããµããªã¡ã³ãã®æå衚瀺ã宿çã«èŠçŽãããšããæç¬ã®é·æçãªå¥åº·ãå®ãç¬¬äžæ©ã§ãã
ð± ç«ãã¥ãŒã¹ â 2026.04.21
æ¬æ¥ 5ä»¶
1. ð¥ å»çã»çŸç ã»äºé²
ç«ã®è¥å€§åå¿ççïŒHCMïŒã«äžçåã®FDAæ¡ä»¶ä»ãæ¿èªââFelycin-CA1ïŒã·ããªã ã¹é æŸæ§é ïŒãå¿å®€è¥å€§ã®é²è¡ãæå¶ïŒTriviumVetïŒ
ð 2025.12.17
TriviumVet瀟ãéçºããFelycin-CA1ïŒsirolimus delayed-release tabletsãã·ããªã ã¹é æŸæ§é ïŒããç±³åœFDAããç«ã®è¥å€§åå¿ççïŒHCMïŒã«ãããå¿å®€è¥å€§ç®¡çã«å¯ŸããŠäžçåã®æ¡ä»¶ä»ãæ¿èªãååŸãããHCMã¯ç«ã«æãå€ãå¿çŸæ£ã§ãäžé«éœ¢ã®ç«ã®çŽ15ã20%ã«èªããããçªç¶æ»ã®äž»å ãšããªããããããŸã§é²è¡ãé ãããæ¿èªè¬ãååšããªãã£ããã·ããªã ã¹ã¯ããã®èåšç§»æ€ã«ãããŠå ç«æå¶è¬ãšããŠäœ¿çšãããè¬å€ã ããäœçšéïŒ0.3mg/kgãé±1åçµå£æäžïŒã§ã¯å¿ç现èã®è¥å€§ãä¿é²ããmTORçµè·¯ãé»å®³ããå¿å®€å£ã®è¥åé²è¡ãæå¶ããã6ãæéã®èšåºè©Šéšã§ææãªæå¶å¹æã確èªãããã
ç«ã®ç³å°¿ç ãŸãã¯æ¢åã®èçŸæ£ãããå Žåã¯äœ¿çšçŠå¿ã§ãããåŠæ¹åã«å¿ ãèæ©èœæ€æ»ãå¿ èŠã ããŸãæ¡ä»¶ä»ãæ¿èªã§ãããããã¡ãŒã«ãŒã¯5幎以å ã«å®å šãªæå¹æ§ããŒã¿ãæåºãã矩åãè² ããããã¯ç¡çç¶HCMïŒåèšåºæïŒãæ©æã«çºèŠããç«ã«åããŠå»ççéžæè¢ãçãŸããããšãæå³ãããšã³ãŒæ€èšºã«ããæ©æçºèŠãšçµã¿åãããããšã§ç«ã®å¿çŸæ£ç®¡çã«æ°æä»£ãããããå¯èœæ§ãããããããã€ãå»ãžã®çžè«ãã
ð·ïž å»çã»çŸç ã»äºé²
2. 𧬠ç ç©¶ã»ç§åŠ
FIPãŠã€ã«ã¹ãBã»Tå ç«çްèã«ææââUC Davisãã³ãããŠã€ã«ã¹ã®åžžèãèŠãæ°çºèŠããã³ã°COVIDãšã®å ±éç¹ïŒVeterinary Microbiology, January 2026ïŒ
ð 2026.01.14
ã«ãªãã©ã«ãã¢å€§åŠããŒãã¹æ ¡ã®ç ç©¶ããŒã ãVeterinary MicrobiologyèªïŒ2026幎1æïŒã«çºè¡šããç ç©¶ã§ãç«ã³ãããŠã€ã«ã¹ïŒFCoVïŒãåŒãèµ·ããç«äŒææ§è ¹èçïŒFIPïŒã®ç æ æ©æ§ã«é¢ããæ°çºèŠãå ±åãããã䞻任ç ç©¶è Amir Kolå士ãã¯ããããŸã§FCoVã¯äž»ã«ãã¯ããã¡ãŒãžïŒåçïŒã«ææãããšãããŠããããå®éã«ã¯Bãªã³ãçã»Tãªã³ãçãå«ãåºç¯ãªå ç«çްèã«ææãããããå ç«çްèã®å éšã§ãŠã€ã«ã¹ã掻çºã«è€è£œããŠããããšãæããã«ãããå ç«çްèèªäœããŠã€ã«ã¹éæ¬è»ãšãªãå šèº«ã«ææãåºããããšã§ãå€èåšã®æ¿ããççããçç¶ãæç¶ã»åçããFIPã®ç æ ã説æã§ããã
ãã®çºèŠã¯ãããã®ãã³ã°COVIDãä»ã®ã³ãããŠã€ã«ã¹é¢é£çŸæ£ã®çè§£ã«ãéèŠãªç€ºåãäžãããšããŠæ³šç®ãããŠãããFIPã¯SARS-CoV-2ãåºçŸããåãããã³ãããŠã€ã«ã¹ãåŒãèµ·ããççæ§å šèº«çŸæ£ã®å®äžçã¢ãã«ããšããŠç ç©¶è ã«éèŠãããŠããçµç·¯ããããä»åã®ç¥èŠã¯æ ¢æ§ççã¡ã«ããºã ã®æ®éççè§£ãæ·±ããå¯èœæ§ãããã飌ãäž»ãšããŠã¯ãFIPã®æ©ææ²»çãè¿·ããå§ããããšã®éèŠæ§ãæ¹ããŠç€ºãããçµæã§ãããã
ð·ïž ç ç©¶ã»ç§åŠ
3. ð¥ å»çã»çŸç ã»äºé²
ç«CKDå䜵ã®éåçæ§è²§è¡ã«ãVarenzin-CA1ïŒã¢ãªãã¥ã¹ã¿ããïŒãââFDAãç«åãåã®è²§è¡æ²»çè¬ãšããŠæ¡ä»¶ä»ãæ¿èªïŒElancoïŒ
ð 2025.10.01
Elanco瀟ã®Varenzin-CA1ïŒmolidustat oral suspensionãã¢ãªãã¥ã¹ã¿ããçµå£æžæ¿æ¶²ïŒããæ ¢æ§è èç ïŒCKDïŒã«äŒŽãéåçæ§è²§è¡ãæ±ããç«ã«å¯Ÿããåã®FDAæ¡ä»¶ä»ãæ¿èªè¬ãšãªã£ããCKDã¯äžé«éœ¢ç«ã®æãäžè¬çãªçŸæ£ã®äžã€ã§ããã®çµæãšããŠçããè²§è¡ã¯åŠæ æã»é£æ¬²äœäžã»äœéæžå°ãªã©ç掻ã®è³ªã倧ããæãªãããããŸã§ç«ã®éåçæ§è²§è¡ã«ã¯æ¿èªè¬ããªããããçšãšãªã¹ãããšãã³è£œå€ã®é©å¿å€äœ¿çšã茞è¡ãªã©ãè¡ãããŠãããVarenzin-CA1ã¯äœé žçŽ èªå°å åïŒHIFïŒãããªã«æ°Žé žåé µçŽ ãé»å®³ããå å æ§ãšãªã¹ãããšãã³ç£çãä¿é²ããããšã§èµ€è¡çé è¡ãå¢å ãããäœçšæ©åºãæã€ã
çšæ³ã¯1æ¥1åçµå£æäžã§æå€§28æ¥éãå¿ èŠã«å¿ããŠ7æ¥éã®äŒè¬æéåŸã«åæäžå¯èœã ãæ¡ä»¶ä»ãæ¿èªã«ãããç«ã®CKD管çã«ãããŠéèŠãªæªå è¶³ããŒãºãžã®å¯Ÿå¿ãåããŠå¯èœãšãªã£ããCKDãæ±ããç«ãå æ°ããªãã»æ¯äžŠã¿ãæªãã»é£æ¬²ãäœäžããŠãããªã©ã®çç¶ã瀺ãå Žåã¯è²§è¡ãèæ¯ã«ããå¯èœæ§ããããè¡æ¶²æ€æ»ãå«ã宿æ€èšºãšç£å»åž«ãžã®çžè«ã匷ããå§ãããã
ð https://my.elanco.com/us/campaign/varenzin
ð·ïž å»çã»çŸç ã»äºé²
4. ð¬ ç ç©¶ã»ç§åŠ
ãæè¡äžèŠã®ç涯é¿åŠããçŸå®ãžââAMHéºäŒåæ²»çãåææ¥æã®éç«ã«1åæ³šå°ã§å®å šäžåŠãé·ææç¶ïŒNature Communications, 2025ïŒ
ð 2025.10.15
Nature CommunicationsèªïŒ2025幎ïŒã«æ²èŒãããç ç©¶ã§ãã¢ããé䌎ãŠã€ã«ã¹ïŒAAVïŒãã¯ã¿ãŒãçšããæãã¥ã©ãŒç®¡ãã«ã¢ã³ïŒAMHïŒéºäŒåæ²»çãåææ¥æã®éç«ã«å¯ŸããŠå®å šãã€å®å šãªé·æé¿åŠå¹æã瀺ãããšã確èªããããAMHé¡äŒŒäœãéºäŒåæäœããAAVãã¯ã¿ãŒãçèå æäžãããšãç«ã®è¡äžAMHæ¿åºŠãéåžžã®1,000å以äžã«äžæãã9ãæä»¥äžã«ãããæç¶ããããã®é«æ¿åºŠAMHãåµå·£ã®åå§åµèãæå¶ããæåµèªçºãé»å®³ããããšã§ãå®éã«éç«ãšäº€é ãããŠãå®å šã«åŠåš ããªãã£ããæäžããç«ã«é節ãªå¯äœçšã¯èŠãããªãã£ãã
äžçã«ã¯æšå®6åå¹ä»¥äžã®éè¯ç«ã»æªç®¡çç«ãçæ¯ããŠãããå€ç§çé¿åŠã®å®æœãå°é£ãªå°åãå€§èŠæš¡ä¿è·æŽ»åã§ã®åäœæ°ç®¡çã«é©åœãããããå¯èœæ§ããããçŸæç¹ã§ã¯è£œååã«å¿ èŠãªçç£ã€ã³ãã©ãæŽã£ãŠããªããããåçšåã«ã¯ãŸã æ°å¹ŽãèŠãããšã¿ããããããã飌ãç«ã®é¿åŠãã1åã®æ³šå°ã§ç涯察å¿å¯èœãã«ãªãæªæ¥ã¯ç¢ºå®ã«è¿ã¥ããŠãããç£å»åŠã®æ¬¡äžä»£æè¡ãšããŠå€§ããªæ³šç®ãéããŠããã
ð https://www.nature.com/articles/s41467-025-65780-2
ð·ïž ç ç©¶ã»ç§åŠ
5. ð¬ ç ç©¶ã»ç§åŠ
FeLVã¯ã¯ãã³æäœå¿çã«æ§å¥ã»è¿œå æ¥çš®ééã»æäžéšäœã圱é¿ââæé©åæ¥çš®ãããã³ã«çå®ã«åããç³»çµ±çæ€èšŒïŒJFMS, 2025ïŒ
ð 2025.11.01
Journal of Feline Medicine and SurgeryïŒJFMSã2025幎ïŒã«æ²èŒãããç ç©¶ïŒPMC12411714ïŒã§ãç«çœè¡ç ãŠã€ã«ã¹ïŒFeLVïŒã¯ã¯ãã³æ¥çš®ã«ãããæäœå¿çã«åœ±é¿ããè€æ°ã®å åãåããŠç³»çµ±çã«æ€èšŒããããæ§å¥ã»è¿œå æ¥çš®ã¹ã±ãžã¥ãŒã«ïŒ3é±é vs 4é±éééïŒã»æäžéšäœïŒè©ç²éªšäž vs ç®äžä»éšäœïŒã»ã¯ã¯ãã³çš®é¡ïŒäžæŽ»åå šç²åã¯ã¯ãã³ vs ã«ããªã¢ããã¯ã¹ãŠã€ã«ã¹ãã¯ã¿ãŒã¯ã¯ãã³ïŒã®éãã«ããæäœäŸ¡ã®å·®ç°ãåæããããã®çµæãè¿œå æ¥çš®ã®ééãæäžéšäœãã¯ã¯ãã³ã¿ã€ãã«ãã£ãŠæäœå¿çã«ææå·®ãããããšã瀺ãããç¹ã«å®å°æ¡ä»¶ã§æ¥çš®ã¹ã±ãžã¥ãŒã«ãä¹±ãããã飌ãç«ã«ãããŠæäœäŸ¡ãååã«éããªãã±ãŒã¹ãããããšã瀺åãããã
FeLVã¯ç«ã«è «çã»å ç«äžå šã»è²§è¡ãªã©ãåŒãèµ·ããæªæ§ãŠã€ã«ã¹ã§ãç¹ã«å±å€ç«ãå€é 飌è²ç«ã§ã¯ææãªã¹ã¯ãé«ããä»åã®ç ç©¶ã¯ãåãã¯ã¯ãã³ã§ãæ¥çš®ã®ããæ¹ã§é²åŸ¡å¹æãå€ããããšããå®è·µçç¥èŠãæäŸãããã®ã ã飌ãç«ã®FeLVã¯ã¯ãã³ãé©åãªã¹ã±ãžã¥ãŒã«ã§å®æœãããŠããããæ¬¡åã®å®æå¥èšºæã«ç£å»åž«ã«ç¢ºèªããããšã匷ããå§ãããã
ð https://pmc.ncbi.nlm.nih.gov/articles/PMC12411714/
ð·ïž ç ç©¶ã»ç§åŠ
ð¡ 仿¥ã®ã¯ã³ãã€ã³ã
ç«ã®å¿èç ã»è èç ã»ãŠã€ã«ã¹ææçã¯ããããããæ©æçºèŠããæ²»çæåã®éµãæ¡ã£ãŠããŸãã幎1ã2åã®å®æå¥èšºã§ãšã³ãŒã»è¡æ¶²æ€æ»ã»å°¿æ€æ»ãçµã¿åãããããšã§ãçç¶ãçŸããåããåé¡ãææ¡ã§ããŸããæç«ããæè¿ã¡ãã£ãšå æ°ããªãããªããšæããããå¥èšºãäžçªã®è¿éã§ãã
æ¯æ7æé ä¿¡

ã³ã¡ã³ããæ®ã